Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Abbott puts the A in AMO

This article was originally published in The Tan Sheet

Executive Summary

The Abbott Park, Ill.-based health care company completes its acquisition of Advanced Medical Optics - now Abbott Medical Optics - which is No. 3 in the contact lens care market, Abbott says Feb. 26. The European Commission gave the merger final clearance Feb. 20, Abbott says. Santa Ana, Calif.-based AMO reported net sales of $285.2 million, a drop of 6.4 percent, in its final independent fiscal quarter (1"The Tan Sheet" Feb. 23, 2009, In Brief). ... Similac in Singapore: Abbott opens its $300 million nutritional manufacturing facility, its single largest investment in Asia to date. Abbott says Feb. 26 it built the facility in response to increased demand for Similac and other pediatric nutritionals. The facility can serve up to 1 million Asian children annually (2"The Tan Sheet" April 24, 2006, p. 10). Abbott also plans to base a nutrition science research and development center in Singapore, the firm says

You may also be interested in...



Mead Johnson seeks U.S. turnaround

The nutritionals company relies on product launches and rebranding, along with packaging innovations, to reclaim market share in the U.S. from Abbott Nutrition. Net sales in North America and Europe during Mead Johnson's third quarter plummeted 16.5 percent to $286 million. The Glenview, Ill.-based company is introducing products in the U.S. at a record rate to compete with recent Abbott launches, "and we are beginning to see signs of stabilization," said CEO Stephen Golsby during an Oct. 22 earnings call. The firm's Asia/Latin America segment grew 4.9 percent with $413.8 million in net sales during the July-September period. Mead Johnson plans to expand distribution in China and establish a pediatric nutrition institute there, Golsby said. Abbott is developing a similar facility in Singapore (1"The Tan Sheet" March 2, 2009, In Brief). Additionally, Golsby said Mead Johnson has hired Tim Brown, formergeneral manager of Procter & Gamble's North America Personal Health Division, as general manager of its U.S. business

AMO’s last independent quarter

Advanced Medical Optics' fiscal 2008 net sales rose 8.6 percent to $1.2 billion despite net sales falling 6.4 percent to $285.2 million in the fourth quarter. The Santa Ana, Calif.-based firm says Feb. 20 that the quarterly drop primarily was due to poor refractive sales, which fell 24.8 percent to $87.1 million in the quarter because consumers have less discretionary money for eye procedures. However, eye-care product sales rose 8.3 percent to $54.7 million in the quarter, led by a 21.9 percent increase in multipurpose solution sales to $24.5 million and by sales of artificial tears, part of the "other" category, which was up 12.3 percent to $15 million. Abbott is acquiring AMO for $22 per share in cash for a total $2.8 billion (1"The Tan Sheet" Feb. 9, 2009, In Brief)

Abbott Singapore Nutritionals Plant Will Be Operational In 2008, Firm Says

The construction of a $280 mil. nutritional powder manufacturing plant in Singapore by Abbott Laboratories will help the company achieve its goal of expanding its presence in the Asian nutritionals market, the firm said during a groundbreaking ceremony April 21

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS102648

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel